MYGN
E561081
MYGN is the stock ticker symbol for Myriad Genetics, a molecular diagnostic company specializing in genetic testing for cancer risk and other hereditary conditions.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| Myriad Genetics, Inc. | 0 |
Statements (31)
| Predicate | Object |
|---|---|
| instanceOf |
molecular diagnostics company
ⓘ
public company ⓘ stock ticker symbol ⓘ |
| aimsTo |
assess disease risk
ⓘ
guide treatment decisions ⓘ |
| analyzes |
DNA
ⓘ
genetic variants ⓘ |
| businessModel | commercial genetic testing services ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| exchange | NASDAQ NERFINISHED ⓘ |
| focusesOn |
personalized medicine
ⓘ
precision medicine ⓘ |
| foundedAs | Myriad Genetics NERFINISHED ⓘ |
| hasTickerSymbol | MYGN NERFINISHED ⓘ |
| headquartersLocation | Salt Lake City, Utah, United States NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
molecular diagnostics ⓘ |
| listedOn | NASDAQ ⓘ |
| offers |
BRCA gene testing
ⓘ
hereditary breast cancer risk tests ⓘ hereditary ovarian cancer risk tests ⓘ multigene panel tests ⓘ |
| providesServicesTo |
healthcare providers
ⓘ
patients ⓘ |
| represents | Myriad Genetics, Inc. NERFINISHED ⓘ |
| sector | healthcare ⓘ |
| securityType | common stock ⓘ |
| specializesIn |
cancer risk assessment
ⓘ
genetic testing ⓘ hereditary cancer testing ⓘ hereditary condition testing ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.